Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter Phase II Randomized Trial to Evaluate Systemic Therapy Versus Systemic Therapy in Combination with Stereotactic Radiotherapy in Patients with Metastatic Colorectal Cancer

NCT05375708 is registered in ClinicalTrials.gov with UMC Utrecht as lead sponsor.

NCT NCT05375708
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05375708 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter Phase II Randomized Trial to Evaluate Systemic Therapy Versus Systemic Therapy in Combination with Stereotactic Radiotherapy in Patients with Metastatic Colorectal Cancer
Lead sponsor
UMC Utrecht
Phase
Phase 2
Overall status
Suspended
Start date
December 1, 2025
Completion date
June 1, 2034
Enrollment
93 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic colorectal cancer, oligometastatic disease